Values First Advisors, Inc. Acelrx Pharmaceuticals Inc Transaction History

Values First Advisors, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Dec 02, 2022	BUY	$0.2 - $0.35 $5,402 - $9,453	27,010 Added 3.52%	794,164 $166,000
Q2 2022 Jul 20, 2022	BUY	$0.18 - $0.29 $22,435 - $36,145	124,639 Added 19.4%	767,154 $187,000
Q1 2022 May 03, 2022	BUY	$0.28 - $0.61 $34,507 - $75,177	123,241 Added 23.73%	642,515 $183,000
Q4 2021 Mar 10, 2022	BUY	$0.49 - $1.02 $254,444 - $529,659	519,274 New	519,274 $291,000
Q3 2021 Nov 15, 2022	SELL	$0.93 - $1.51 $263,402 - $427,675	-283,229 Reduced 36.92%	483,925 $494,000
Q2 2021 Nov 15, 2022	SELL	$1.03 - $1.7 $9,466 - $15,624	-9,191 Reduced 1.97%	457,959 $632,000
Q1 2021 Nov 15, 2022	SELL	$1.25 - $2.77 $375,005 - $831,011	-300,004 Reduced 39.11%	467,150 $794,000
Q4 2020 Nov 15, 2022	SELL	$1.18 - $1.98 $16,063 - $26,953	-13,613 Reduced 2.9%	456,090 $566,000
Q3 2020 Nov 15, 2022	BUY	$1.01 - $1.81 $52,417 - $93,937	51,899 Added 12.42%	469,703 $667,000
Q2 2020 Nov 15, 2022	BUY	$1.03 - $1.69 $172,724 - $283,402	167,694 Added 67.05%	417,804 $506,000
Q1 2020 Jan 09, 2023	SELL	$0.76 - $2.07 $280,477 - $763,931	-369,049 Reduced 46.47%	425,115 $502 Million
Q4 2019 Nov 15, 2022	SELL	$1.66 - $2.4 $858,293 - $1.24 Million	-517,044 Reduced 67.4%	250,110 $528,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Values First Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Values First Advisors, Inc. with notifications on news.